World Vaccine Congress Washington 2025 - the world's largest vaccine event; April 21-24, 2025; Registration is Open

March 21, 2025 | Friday | News

At Walter E. Washington Convention Center, The Congress will bring together thousands of global vaccine experts, policymakers, industry leaders, and researchers to drive forward the latest innovations in vaccines, pandemic preparedness, and public health.

The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event, is officially open for registration. Taking place from April 21-24, 2025, at the Walter E. Washington Convention Center, the Congress will bring together thousands of global vaccine experts, policymakers, industry leaders, and researchers to drive forward the latest innovations in vaccines, pandemic preparedness, and public health.

This must-attend event features a cutting-edge agenda with insights from top government agencies, leading scientists, and global organizations, including representatives from WHO, CEPI, PAHO, government agencies, and industry pioneers.

Why Attend?

Gain exclusive insights into cutting-edge vaccine research, development, manufacturing, and policy
Engage with 550+ speakers, including top government, academic, and industry leaders
Network with 4,000+ attendees from across the vaccine ecosystem
Explore 300+ exhibitors showcasing breakthrough vaccine technologies and solutions

Key Sessions to Attend:

April 21, 14:00 – The Global mPox response
April 22, 10:00 – Keynote panel: H5N1 influenza – how close are we to a pandemic?
April 22, 15:50 - Keynote panel: New Shots on the block – the status of the vaccine pipeline in 2025
April 23, 11:40 - Panel: Do we need a perfectly matching strain in our next COVID vaccines?
April 23, 09:10 - Panel: Is it worth the risk to develop highly innovative cancer vaccines? April 23, 09:05 - Digitalization, automation and artificial intelligence in vaccine manufacturing and supply
April 23, 14:40 - Panel: Mitigating against the continued erosion of public health authorities in the USA
April 24, 11:30 - Panel: Our global maternal and infant RSV intervention strategies
April 24, 14:35 - Keynote closing panel: From bench to bedside – the integration of AI into vaccine research & development

Featured Speakers Include:

Chan Harjivan, FormerAssistant at The White House & Chief Strategy Officer, The Medical Countermeasures Coalition
Dr Ana Maria Henao-Restrepo, MD, MSc, Lead R&D Blueprint for Epidemics, WHO
Georges Benjamin, Executive Director, American Public Health Association
Praneel Jadav, Manager, Infectious Disease Policy, BIO
Santiago Cornejo, Executive Director, Regional Revolving Fund, PAHO
Ritu Banerjee, Assistant Deputy Minister, Office of Life Sciences and Biomanufacturing Canada
Bassam Hallis, Deputy Director, Vaccine Development & Evaluation Centre, UK Health Security Agency
Taylor Sexton, Executive Director, Medical Countermeasures Coalition, Todd Strategy Group
Matthew G. Clark, Joint Project Manager, CBRN Medical, JPEO-CBRND
Dr Seth Berkley, Former CEO, Gavi, Senior Advisor, Pandemic Center at Brown Univertsity
Kent Kester, Executive Director, Vaccine Research and Development, CEPI
Christian Tientcha Happi, Professor of Molecular Biology and Genomics in the Department of Biological Sciences & Director, ACEGID